Detalhe da pesquisa
1.
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
J Pediatr Gastroenterol Nutr
; 75(6): 717-723, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36084231
2.
Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis.
J Pediatr Gastroenterol Nutr
; 66(1): 84-89, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28604509
3.
Mucosal Cytokine Profiles After Induction Therapy With Granulocyte/Monocyte Apheresis in New-onset Inflammatory Colitis.
J Pediatr Gastroenterol Nutr
; 66(4): e103-e107, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28891831
4.
Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment.
Int J Mol Sci
; 18(3)2017 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28272355
5.
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.
Paediatr Drugs
; 2024 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38780740
6.
Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF.
Nat Commun
; 15(1): 1752, 2024 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38409190
7.
The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis.
Cell Rep Med
; 4(5): 101038, 2023 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37160121
8.
Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN.
J Crohns Colitis
; 17(12): 1939-1948, 2023 Dec 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37392064
9.
Exclusive Enteral Nutrition: Clinical Effects and Changes in Mucosal Cytokine Profile in Pediatric New Inflammatory Bowel Disease.
Nutrients
; 11(2)2019 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30781421